These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 38463363)

  • 1. Risk stratification in gastric cancer lung metastasis: Utilizing an overall survival nomogram and comparing it with previous staging.
    Chen ZR; Yang MF; Xie ZY; Wang PA; Zhang L; Huang ZH; Luo Y
    World J Gastrointest Surg; 2024 Feb; 16(2):357-381. PubMed ID: 38463363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of two nomograms for predicting overall survival and cancer-specific survival in gastric cancer patients with liver metastases: A retrospective cohort study from SEER database.
    Dong Z; Zhang Y; Geng H; Ni B; Xia X; Zhu C; Liu J; Zhang Z
    Transl Oncol; 2022 Oct; 24():101480. PubMed ID: 35868142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of two nomograms for predicting overall survival and Cancer-specific survival in prostate cancer patients with bone metastases: a population-based study.
    Li B; Xing J; Wang Z; Gong Z; Wang Z; Xu A
    BMC Urol; 2023 Dec; 23(1):200. PubMed ID: 38049755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
    Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
    BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of prognostic nomogram based on log odds of positive lymph nodes for patients with gastric signet ring cell carcinoma.
    Xu Z; Jing J; Ma G
    Chin J Cancer Res; 2020 Dec; 32(6):778-793. PubMed ID: 33447000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
    Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
    BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.
    Cheng H; Xu JH; Kang XH; Wu CC; Tang XN; Chen ML; Lian ZS; Li N; Xu XL
    J Ovarian Res; 2023 Apr; 16(1):75. PubMed ID: 37059991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of all-cause death and specific causes of death in patients with gastric cancer with liver metastasis: a Surveillance, Epidemiology, and End Results-based study.
    Wu Y; Guo Y; Luo W
    J Gastrointest Surg; 2024 Jun; 28(6):880-888. PubMed ID: 38616463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
    Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
    Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.
    Zuo H; Li MM
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15969-15987. PubMed ID: 37684510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts.
    Wang H; Xia GF; Zhang ZR; Luo X; Zhu JY; Wang HK
    Am J Cancer Res; 2023; 13(11):5065-5081. PubMed ID: 38058820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
    Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
    J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.
    Shi J; Peng B; Wang C; Zhou X; Lu T; Xu R; Chang X; Shen Z; Wang K; Xu C; Zhang L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11779-11790. PubMed ID: 37407846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
    Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
    Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of nomograms for predicting survival in small cell lung cancer patients with brain metastases: a SEER population-based analysis.
    Xiao S; Mei Z; Xie Z; Lu H
    Am J Transl Res; 2024; 16(6):2318-2333. PubMed ID: 39006302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram for the prediction of lymph node metastasis and survival outcomes in rectal neuroendocrine tumour patients undergoing resection.
    Chen Q; Chen J; Deng Y; Zhang Y; Huang Z; Zhao H; Cai J
    J Gastrointest Oncol; 2022 Feb; 13(1):171-184. PubMed ID: 35284104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic nomogram for the cancer-specific survival of white patients with invasive melanoma at BANS sites based on the Surveillance, Epidemiology, and End Results database.
    Huang JN; Yu H; Wan Y; Ming WK; Situ F; Zhu L; Jiang Y; Wu UT; Huang WE; Chen W; Lyu J; Deng L
    Front Med (Lausanne); 2023; 10():1167742. PubMed ID: 37497274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery.
    Ren X; Huang T; Tang X; Ma Q; Zheng Y; Hu Z; Wang Y; Zhou Y
    Front Oncol; 2023; 13():1223857. PubMed ID: 37655111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
    Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
    BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.